Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL614145 Target Snapshot

RT-112 · CELL-LINE · Homo sapiens

268Compounds
89Assays
33Approved Drugs
291.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Confirm a stable target identifier before relying on this context across project surfaces.

Review focus
Open DB context pending

Confirm a stable target identifier before relying on this context across project surfaces.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats RT-112 as ChEMBL target CHEMBL614145. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
RT-112
CELL-LINE · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL614145
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether RT-112 still has a stable protein naming contract across sources.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelRT-112
UniProt AccessionN/A

RT-112

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as RT-112.

Review nameRT-112
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

33
Approved
10
Phase III
14
Phase II
6
Phase I
Assay Mix

Activity Type Distribution

IC50291.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL888 9.89 IC50 0.1273 Approved
CHEMBL3348846 9.22 IC50 0.6 Clinical
CHEMBL94657 9.21 IC50 0.6143 Clinical
CHEMBL3545252 8.93 IC50 1.187 Approved
CHEMBL3545376 8.89 IC50 1.3 Approved
CHEMBL159 8.57 IC50 2.708 Approved
CHEMBL4297522 8.48 IC50 3.3 Approved
CHEMBL553025 8.47 IC50 3.371 Approved
CHEMBL5314537 8.4 IC50 4.0 Clinical
CHEMBL96926 8.38 IC50 4.217 Preclinical
Distribution

pChEMBL Value Distribution

38
5.0
31
5.5
44
6.0
22
6.5
14
7.0
12
7.5
13
8.0
4
8.5
2
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

FUTIBATINIB
CHEMBL3701238
Approved 2022
INFIGRATINIB PHOSPHATE
CHEMBL1834657
Approved 2021
INFIGRATINIB
CHEMBL1852688
Approved 2021
PEMIGATINIB
CHEMBL4297522
Approved 2020
ERDAFITINIB
CHEMBL3545376
Approved 2019
MIDOSTAURIN
CHEMBL608533
Approved 2017
PALBOCICLIB
CHEMBL189963
Approved 2015
PONATINIB
CHEMBL1171837
Approved 2012
TEMSIROLIMUS
CHEMBL1201182
Approved 2007
GEMCITABINE
CHEMBL888
Approved 1996
DOCETAXEL
CHEMBL3545252
Approved 1995
VINORELBINE
CHEMBL553025
Approved 1994
PACLITAXEL
CHEMBL428647
Approved 1992
ETOPOSIDE
CHEMBL44657
Approved 1983
MITOMYCIN
CHEMBL105
Approved 1981
DOXORUBICIN
CHEMBL53463
Approved 1974
CYTARABINE
CHEMBL803
Approved 1969
VINBLASTINE
CHEMBL159
Approved 1965
METHOTREXATE
CHEMBL34259
Approved 1953
Assay Landscape

Assay Landscape

89
Total Assays
210
Tested Compounds
1
Assay Types
Functional — 89 assays, 210 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 80 210 6.0
organism-based format 9 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine